statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations...

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) dropped 6.2% during mid-day trading on Monday . The stock traded as low as $9.16 and last traded at $9.30. Approximately...

Arcutis Biotherapeutics (NASDAQ:ARQT)  Shares Down 6.2%

Patent challenge initiated by Arcutis BiotherapeuticsNESS ZIONA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company pioneering treatments...

Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve  Cream

WESTLAKE VILLAGE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations...

Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Marinus (MRNS Research Report), Arcutis Biotherapeutics...

Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)

Deutsche Bank AG lifted its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT  Free Report) by 13.7% in the third quarter, according to the company in its most recent filing with the...

Deutsche Bank AG Has $161,000 Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

This indicator may be signaling that ARQT's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Arcutis Biotherapeutics (ARQT, $10.15) entered Downtrend as Momentum indicator drops below 0 level on Mar 21, 2024

This indicator may be signaling ARQT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Arcutis Biotherapeutics (ARQT, $10.81) entered Uptrend as Momentum indicator ascends above 0 level on Mar 20, 2024

This is a signal that ARQT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Arcutis Biotherapeutics (ARQT, $9.86) Stochastic Oscillator left the oversold zone on March 19, 2024

Arcutis Biotherapeutics (ARQT, $10.67) entered Downtrend as Momentum indicator drops below 0 level on Mar 15, 2024

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Volume	2M
52-Wk High	$15.21
52-Wk Low	$1.76

ARQT Arcutis Biotherapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals